earnings
confidence high
sentiment neutral
materiality 0.70
AptarGroup Q1 2025: sales down 3% to $887M, adjusted EPS $1.20, guides Q2 EPS $1.56-$1.64
APTARGROUP, INC.
2025-Q1 EPS reported
$1.17
revenue$887,305,000
- Reported sales down 3% to $887M; net income down 5% to $79M; adjusted EPS $1.20 vs $1.22 prior year.
- Pharma core sales +3% on drug delivery systems; Beauty core -3% on lower fragrance; Closures core -2%.
- Adjusted EBITDA $183M (+3%); margin 20.7% (+120 bps) driven by pharma royalties.
- Q2 2025 adjusted EPS guidance $1.56-$1.64; effective tax rate 19%-21% vs 24% adjusted prior year.
- Repurchased 548k shares for $80M; quarterly dividend $0.45/share payable May 22, 2025.